Treatments | Wt. reduction (%) | BD (kg∙m−3) | EC (dS∙m−1) | OM (%) | N (%) | C:N ratio |
T1―OPF + PM | 34.03b | 381.12b | 2.33a | 58.27c | 2.36b | 14.39b |
T2―RH + PM | 34.42b | 296.23c | 1.68bc | 51.02ab | 1.51c | 19.67a |
T3―RS + PM | 44.18a | 442.56a | 1.53c | 59.08bc | 2.45b | 14.07b |
T4―SD + PM | 31.13c | 438.08a | 1.82b | 58.17c | 2.28b | 14.84b |
T5―YW + PM | 43.46a | 401.96b | 1.53c | 60.58a | 2.66a | 13.21c |
LSD0.05 | 1.230 | 33.337 | 0.194 | 1.769 | 0.174 | 0.790 |
Pr > F | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
CV (%) | 2.13 | 5.52 | 7.07 | 5.45 | 4.87 | 3.42 |